Recruiting

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(27 sites)

United States

UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California

Mount Sinai Medical Center, Miami Beach, Florida

Baystate Medical Center, Springfield, Massachusetts

Spectrum Health at Butterworth Campus, Grand Rapids, Michigan

Munson Medical Center, Traverse City, Michigan

Nebraska Methodist Hospital, Omaha, Nebraska

Women's Cancer Center of Nevada, Las Vegas, Nevada

Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey

Memorial Sloan Kettering Monmouth, Middletown, New Jersey

Memorial Sloan Kettering Bergen, Montvale, New Jersey

Memorial Sloan Kettering Commack, Commack, New York

Memorial Sloan Kettering Westchester, Harrison, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Memorial Sloan Kettering Nassau, Uniondale, New York

Duke University Medical Center, Durham, North Carolina

Duke Women's Cancer Care Raleigh, Raleigh, North Carolina

Ohio State University Comprehensive Cancer Center, Columbus, Ohio

ProMedica Flower Hospital, Sylvania, Ohio

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Women and Infants Hospital, Providence, Rhode Island

Avera Cancer Institute, Sioux Falls, South Dakota

Netherlands

Catharina Hospital Eindhoven, Eindhoven

University Medical Center Groningen, Groningen

Leiden University Medical Center, Leiden

Radboud University Medical Center, Nijmegen

Erasmus Medical Center, Rotterdam

University Medical Center Utrecht, Utrecht